Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Lofexidine in Hepatic Impairment
NCT02318836Phase 1Completed
- Sponsor
- US WorldMeds
- Start
- Jun 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of lofexidine in opioid withdrawal (4 arms), sponsored by US WorldMeds. Primary endpoint: Pharmacokinetic Profile. Started Jun 2014; status: completed.
02
Drugs
lofexidine
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT02318836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318836.